Subcutaneous sumatriptan 6 mg is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan because of unpleasant or unwanted side effects. To evaluate ...

The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults. The FDA has approved sumatriptan nasal spray (Tosymra) for the acute ...

California-based Zogenix announced a partnership with Astellas to co-promote Sumavel DosePro, a subcutaneous injection for migraine relief. Approved in July, Sumavel DosePro (sumatriptan injection) ...

Sumatriptan oral tablet is a prescription drug that’s available as the brand-name drug Imitrex. It’s also available as a generic drug. Generic drugs usually cost less. In some cases, they may not be ...

NEW YORK Results from two clinical studies presented at this year’s American Headache Society meeting could help a needle-free migraine drug from Zogenix get Food and Drug Administration approval. The ...

Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology Presentation at the 2nd Annual Drug ...

Tosymra is an intranasal spray containing sumatriptan 10mg, a selective 5-HT1B/1D receptor agonist. The Food and Drug Administration has approved Tosymra (sumatriptan nasal spray; Promius Pharma) for ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) and its subsidiary, Promius Pharma, LLC today announced the approval of ...

TOSYMRA is indicated for the acute treatment of migraine with or without aura in adults. TOSYMRA is a mist-like nasal spray that acts rapidly and is well tolerated. It is formulated using a ...